228 related articles for article (PubMed ID: 28348980)
21. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
22. The Compound U18666A Inhibits the Intoxication of Cells by
Papatheodorou P; Kindig S; Badilla-Lobo A; Fischer S; Durgun E; Thuraisingam T; Witte A; Song S; Aktories K; Chaves-Olarte E; Rodríguez C; Barth H
Front Microbiol; 2021; 12():784856. PubMed ID: 34912322
[TBL] [Abstract][Full Text] [Related]
23. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
24. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.
Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352
[TBL] [Abstract][Full Text] [Related]
26. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
El Hadidy N; Uversky VN; Sun X
Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
[TBL] [Abstract][Full Text] [Related]
27. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
28. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
[TBL] [Abstract][Full Text] [Related]
29. The enterotoxicity of Clostridium difficile toxins.
Sun X; Savidge T; Feng H
Toxins (Basel); 2010 Jul; 2(7):1848-80. PubMed ID: 22069662
[TBL] [Abstract][Full Text] [Related]
30. Systematic Evaluation of Parameters Important for Production of Native Toxin A and Toxin B from
Aminzadeh A; Jørgensen R
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33801738
[TBL] [Abstract][Full Text] [Related]
31. Exploring the inhibitory potential of the antiarrhythmic drug amiodarone against
Schumacher J; Nienhaus A; Heber S; Matylitsky J; Chaves-Olarte E; Rodríguez C; Barth H; Papatheodorou P
Gut Microbes; 2023 Dec; 15(2):2256695. PubMed ID: 37749884
[TBL] [Abstract][Full Text] [Related]
32. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
33. Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of
Schöttelndreier D; Langejürgen A; Lindner R; Genth H
Front Cell Infect Microbiol; 2020; 10():565465. PubMed ID: 33194803
[TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
35. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
36. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
[TBL] [Abstract][Full Text] [Related]
37. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
Zhang Y; Hamza T; Gao S; Feng H
Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
[TBL] [Abstract][Full Text] [Related]
38. Evidence for dual receptor-binding sites in Clostridium difficile toxin A.
Lambert GS; Baldwin MR
FEBS Lett; 2016 Dec; 590(24):4550-4563. PubMed ID: 27861794
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.
Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Lacy DB
Infect Immun; 2016 Oct; 84(10):2871-7. PubMed ID: 27456833
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
